An integrative sparse boosting analysis of cancer genomic commonality and difference
Not on the map. Why?
Abstract (arXiv)
In cancer research, high-throughput profiling has been extensively conducted. In recent studies, the integrative analysis of data on multiple cancer patient groups/subgroups has been conducted. Such analysis has the potential to reveal the genomic commonality as well as difference across groups/subgroups. However, in the existing literature, methods with a special attention to the genomic commonality and difference are very limited. In this study, a novel estimation and marker selection method based on the sparse boosting technique is developed to address the commonality/difference problem. In terms of technical innovation, a new penalty and computation of increments are introduced. The proposed method can also effectively accommodate the grouping structure of covariates. Simulation shows that it can outperform direct competitors under a wide spectrum of settings. The analysis of two TCGA (The Cancer Genome Atlas) datasets is conducted, showing that the proposed analysis can identify markers with important biological implications and have satisfactory prediction and stability.
Key facts. Cited by 1 paper in the map (data through 7 Oct 2026). First posted on arXiv 28 Nov 2022.
Builds on
No reference list yet.
Built on by
Citing papers per year: 2023: 1.
1 paper.